Haverford Financial Services Inc. reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 10.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 20,278 shares of the healthcare conglomerate’s stock after selling 2,429 shares during the period. UnitedHealth Group makes up approximately 3.1% of Haverford Financial Services Inc.’s investment portfolio, making the stock its 15th biggest holding. Haverford Financial Services Inc.’s holdings in UnitedHealth Group were worth $10,258,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also made changes to their positions in UNH. Raymond James Financial Inc. purchased a new stake in UnitedHealth Group during the 4th quarter valued at about $1,914,740,000. Amundi boosted its holdings in UnitedHealth Group by 97.2% in the 4th quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate’s stock valued at $3,183,132,000 after purchasing an additional 2,991,470 shares during the last quarter. Proficio Capital Partners LLC boosted its holdings in UnitedHealth Group by 76,830.4% in the 4th quarter. Proficio Capital Partners LLC now owns 1,888,641 shares of the healthcare conglomerate’s stock valued at $955,388,000 after purchasing an additional 1,886,186 shares during the last quarter. Caisse DE Depot ET Placement DU Quebec boosted its holdings in UnitedHealth Group by 129.7% in the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,029,540 shares of the healthcare conglomerate’s stock valued at $601,951,000 after purchasing an additional 581,324 shares during the last quarter. Finally, State Street Corp boosted its holdings in UnitedHealth Group by 1.3% in the 3rd quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock valued at $26,626,387,000 after purchasing an additional 563,554 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.
UnitedHealth Group Stock Up 1.3 %
Shares of NYSE:UNH opened at $517.72 on Friday. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The company’s fifty day moving average is $510.19 and its 200-day moving average is $547.11. The company has a market capitalization of $473.57 billion, a PE ratio of 33.40, a P/E/G ratio of 1.37 and a beta of 0.62.
UnitedHealth Group Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.62%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is currently 54.19%.
Analyst Ratings Changes
UNH has been the topic of several recent analyst reports. Cantor Fitzgerald restated an “overweight” rating and issued a $700.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective on the stock in a report on Friday, January 10th. Oppenheimer upped their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Wells Fargo & Company reduced their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. Finally, Deutsche Bank Aktiengesellschaft increased their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. Twenty analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average target price of $629.32.
Insider Transactions at UnitedHealth Group
In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction on Friday, January 17th. The shares were purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.33% of the company’s stock.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
- Five stocks we like better than UnitedHealth Group
- Should You Invest in Penny Stocks?
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- Why Are Stock Sectors Important to Successful Investing?
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- Stock Analyst Ratings and Canadian Analyst Ratings
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.